Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons - PubMed (original) (raw)
. 2012 Nov 15;21(22):4827-35.
doi: 10.1093/hmg/dds352. Epub 2012 Aug 21.
Affiliations
- PMID: 22914740
- DOI: 10.1093/hmg/dds352
Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons
Seungmin Lee et al. Hum Mol Genet. 2012.
Abstract
Mitochondrial dysfunction is implicated in aging and degenerative disorders such as Parkinson's disease (PD). Continuous fission and fusion of mitochondria shapes their morphology and is essential to maintain oxidative phosphorylation. Loss-of-function mutations in PTEN-induced kinase1 (PINK1) or Parkin cause a recessive form of PD and have been linked to altered regulation of mitochondrial dynamics. More specifically, the E3 ubiquitin ligase Parkin has been shown to directly regulate the levels of mitofusin 1 (Mfn1) and Mfn2, two homologous outer membrane large GTPases that govern mitochondrial fusion, but it is not known whether this is of relevance for disease pathophysiology. Here, we address the importance of Mfn1 and Mfn2 in midbrain dopamine (DA) neurons in vivo by characterizing mice with DA neuron-specific knockout of Mfn1 or Mfn2. We find that Mfn1 is dispensable for DA neuron survival and motor function. In contrast, Mfn2 DA neuron-specific knockouts develop a fatal phenotype with reduced weight, locomotor disturbances and death by 7 weeks of age. Mfn2 knockout DA neurons have spherical and enlarged mitochondria with abnormal cristae and impaired respiratory chain function. Parkin does not translocate to these defective mitochondria. Surprisingly, Mfn2 DA neuron-specific knockout mice have normal numbers of midbrain DA neurons, whereas there is a severe loss of DA nerve terminals in the striatum, accompanied by depletion of striatal DA levels. These results show that Mfn2, but not Mfn1, is required for axonal projections of DA neurons in vivo.
Similar articles
- Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit.
Pham AH, Meng S, Chu QN, Chan DC. Pham AH, et al. Hum Mol Genet. 2012 Nov 15;21(22):4817-26. doi: 10.1093/hmg/dds311. Epub 2012 Jul 31. Hum Mol Genet. 2012. PMID: 22859504 Free PMC article. - Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
Zhao F, Wang W, Wang C, Siedlak SL, Fujioka H, Tang B, Zhu X. Zhao F, et al. Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1359-1370. doi: 10.1016/j.bbadis.2017.02.016. Epub 2017 Feb 16. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 28215578 Free PMC article. - Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development.
Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Chen H, et al. J Cell Biol. 2003 Jan 20;160(2):189-200. doi: 10.1083/jcb.200211046. Epub 2003 Jan 13. J Cell Biol. 2003. PMID: 12527753 Free PMC article. - Beyond Deubiquitylation: USP30-Mediated Regulation of Mitochondrial Homeostasis.
Hou J, Eldeeb M, Wang X. Hou J, et al. Adv Exp Med Biol. 2017;1038:133-148. doi: 10.1007/978-981-10-6674-0_10. Adv Exp Med Biol. 2017. PMID: 29178074 Review. - Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H. Büeler H. Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18. Exp Neurol. 2009. PMID: 19303005 Review.
Cited by
- Mechanism study of YangJing ZhongYu decoction on regulating mitochondrial dynamics of ovarian granular cells and improving diminished ovarian reserve.
Li P, Kuang J. Li P, et al. J Ovarian Res. 2024 Sep 17;17(1):188. doi: 10.1186/s13048-024-01506-0. J Ovarian Res. 2024. PMID: 39289738 Free PMC article. - Ablation of Mitochondrial RCC1-L Induces Nigral Dopaminergic Neurodegeneration and Parkinsonian-like Motor Symptoms.
Ellioff KJ, Osting SMK, Lentine A, Welper AD, Burger C, Greenspan DS. Ellioff KJ, et al. bioRxiv [Preprint]. 2024 Mar 29:2023.12.01.567409. doi: 10.1101/2023.12.01.567409. bioRxiv. 2024. PMID: 38585782 Free PMC article. Preprint. - The mitochondrial quality control system: a new target for exercise therapeutic intervention in the treatment of brain insulin resistance-induced neurodegeneration in obesity.
Cai M, Wan J, Cai K, Li S, Du X, Song H, Sun W, Hu J. Cai M, et al. Int J Obes (Lond). 2024 Jun;48(6):749-763. doi: 10.1038/s41366-024-01490-x. Epub 2024 Feb 20. Int J Obes (Lond). 2024. PMID: 38379083 Review. - The role of mitochondrial dynamics in disease.
Wang Y, Dai X, Li H, Jiang H, Zhou J, Zhang S, Guo J, Shen L, Yang H, Lin J, Yan H. Wang Y, et al. MedComm (2020). 2023 Dec 28;4(6):e462. doi: 10.1002/mco2.462. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38156294 Free PMC article. Review. - Atypical peripheral actin band formation via overactivation of RhoA and nonmuscle myosin II in mitofusin 2-deficient cells.
Wang Y, Troughton LD, Xu F, Chatterjee A, Ding C, Zhao H, Cifuentes LP, Wagner RB, Wang T, Tan S, Chen J, Li L, Umulis D, Kuang S, Suter DM, Yuan C, Chan D, Huang F, Oakes PW, Deng Q. Wang Y, et al. Elife. 2023 Sep 19;12:e88828. doi: 10.7554/eLife.88828. Elife. 2023. PMID: 37724949 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials